Skip to main content
. 2014 Jun 26;29(4):216–223. doi: 10.1097/YIC.0000000000000032

Table 4.

Factors associated with risk of discontinuation of acetylcholinesterase inhibitor therapy among those diagnosed with Alzheimer’s disease in 2005 in the MEDALZ-2005 study

graphic file with name yic-29-216-g004.jpg